Most Recent
Banksia judge made no allowance for ‘youth and inexperience’ of Mark Elliott’s son, appeal says
Appeals 2021-11-26 12:48 pm By Christine Caulfield

The judge who made findings against the son of the mastermind behind the Banksia class action scam may have formed strong views about the 27-year-old’s role before he testified and used the flawed suggestion that he was his father’s right-hand man as an “evidential gap filler”, an appeals court has been told.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Beach Energy faces second shareholder class action
Energy & Natural Resources 2021-11-26 5:34 pm By Christine Caulfield

Beach Energy has been hit with a second shareholder class action in as many days over allegedly misleading earnings projections for its Western Flank oil and gas reserves in the Cooper Basin.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘This is ridiculous’: Judge pans Google’s bid for confidentiality in John Barilaro’s case
Defamation 2021-11-26 2:24 pm By Christine Caulfield

A bid by Google for a confidentiality undertaking by former NSW Deputy Premier John Barilaro over evidence produced in the politician’s defamation case has earned a sharp rebuke by a judge.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ANZ hit with ASIC action over $18.5B home loan ‘introducer’ program
Financial Services 2021-11-26 8:53 am By Christine Caulfield

The Australian Securities and Investments Commission has launched court proceedings against ANZ alleging the banking giant’s home loan ‘introducer’ referral program breached credit laws.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Controversial class action bill passes House by slim margin
Class Actions 2021-11-24 10:27 pm By Christine Caulfield

The federal government’s latest class action reform bill that would effectively cap legal fees and funding commissions has narrowly passed the House of Representatives.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Greensill Bank says IAG unit owes $48.5M under trade credit policy
Restructuring & Insolvency 2021-11-24 10:15 pm By Christine Caulfield

The insolvency administrator of Germany-based Greensill Bank AG has launched court proceedings against Insurance Australia Limited seeking US$35 million allegedly owed under a policy indemnifying the collapsed financial services firm for unrecovered debts.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Romeo’s settles two underpayments class actions
Class Actions 2021-11-23 1:26 pm By Christine Caulfield

Supermarket chain Romeo’s has reached a settlement in two class actions alleging staff were underpaid, but details of the agreements are scant.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis unit Sandoz sues to revoke Bayer’s patents for blood thinner Xarelto
Intellectual Property 2021-11-23 3:30 pm By Christine Caulfield

Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Banksia class action barristers declare bankruptcy after $21.7M judgment
Class Actions 2021-11-19 9:39 pm By Christine Caulfield

Two former barristers ordered to pay at least $21.7 million in damages and costs for their role in a fraudulent scheme to pocket a windfall from the Banksia Securities class action have filed for bankruptcy.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Pfizer wins more docs in preliminary discovery saga over Enbrel biosimilar
Intellectual Property 2021-11-18 12:46 pm By Christine Caulfield

Five years into a preliminary discovery application for a potential patent infringement lawsuit over a biosimilar of its Enbrel medication, Pfizer has partially succeeded in obtaining further documents from Samsung Bioepis.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?